Restless legs syndrome (RLS) is a neurological disorder characterized by an irrepressible need to move the legs. This syndrome also known as Willis-Ekbom disease and Wittmaack-Ekbom syndrome, can occur at any age. The symptoms of the disorder tend to worsen during the night, what induce sleep difficulties and significantly impacting quality of life. Currently, there…
Cannabidiol (CBD) a non-psychoactive compound from the cannabis plant have been shown to have a positive effect against many dermatological disorders such as eczema, psoriasis, pruritis, and inflammatory conditions. One of the important systems in our body is the Endocannabinoid System (ECS). It plays the role of molecular signaling network, important for the modulation of…
Fibromyalgia is a chronic pain syndrome, often accompanied be sleeping disturbances, chronic musculoskeletal pain, fatigue, and mood disturbances. The pathogenesis of fibromyalgia is not clear. It usually affects women more than men and has a genetic preponderance. Fibromyalgia can have physical and psychological, impacts on patients. Unfortunately, in most patients, fibromyalgia is chronic. Usual medications…
Over last few years researchers’ attention has been focused on use of medical cannabis due to global regulatory loosening. This fact significantly increased cannabinoid therapeutics analytical data in psychiatric field. Many of them suggest that cannabinoid might improve depressive disorders and symptoms, anxiety disorders, attention-deficit hyperactivity disorder, Tourette syndrome, post-traumatic stress disorder, or psychosis. Moreover,…
Epilepsy is one of the most common non-transmissible neurological diseases. It is defined as a brain disorder that predisposes to seizures and has associated physical, psychological and social consequences. Approximately one-third of patients with epilepsy have seizures that are resistant to antiepileptic medications. These patients do not respond well to the conventional antiepileptic drugs. Moreover,…
Several recent laboratory studies of cannabidiol, or CBD, have shown promising results in the context of prevention the coronavirus infection. The study performed by the team of Marsha Rosner of the University of Chicago (USA) recently published evidence that CBD could block the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) responsible for COVID-19. Their study published…
Content of the publication: A new study regarding the prevention of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection responsible for COVID-19 was published on January 10, 2022, in the scientific journal “The Journal of Natural Products”[1]. Researchers from the Oregon Health and Science University in Portland (USA) have demonstrated the potential of cannabinoids to…
No products in the cart.